SHELTON, CT / ACCESS Newswire / June 29, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

The year 2026 marked the 20th anniversary of the publication of the European Medicines Agency (EMA) reflection paper on ...

WHO's first guidance on paediatric dengue treatments is a significant step toward improving care for children affected by ...

Incidence of medication problems and their harm potential following hospital discharge among pediatric patients with epilepsy were not significantly different for individuals who received discharge ...

In addition to healthy weight reduction through lifestyle changes, experts recommend anti-obesity medications and bariatric surgery to help manage metabolic dysfunction–associated steatotic liver ...

Medication errors in pediatric care remain a significant healthcare challenge despite technological advancements, necessitating innovative approaches. This study aims to evaluate Large Language Models ...

Hope is on the horizon for sick children requiring intravenous canulation to administer medication. A Griffith University–led randomized controlled trial has provided evidence about the most effective ...

Upon request of her oncology team, a nine-year-old female patient attended the Belfast Paediatric Dental Department for dental screening before commencement of intravenous denosumab. The patient had a ...

Several persistent yet nonspecific symptoms have been reported in individuals who have previously recovered from infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). This ...

Please provide your email address to receive an email when new articles are posted on . From 2009 to 2020, emergency department visits for unsupervised pediatric medication exposures decreased by ...

Hamad Medical Corporation (HMC) has launched two advanced diagnostic services for pediatric allergies: skin allergy testing to accurately identify food and env ...

Pharmacologic treatment in children and adolescents with psychiatric disorders reduces the risk of substance use later in life, especially in ADHD. Earlier-onset and longer-lasting treatment were most ...